Elevation Oncology Inc

NASDAQ:ELEV   3:57:33 PM EDT
5.20
+0.85 (+19.54%)
Earnings Announcements

Elevation Oncology Reports Third Quarter 2021 Financial Results

Published: 11/12/2021 12:47 GMT
Elevation Oncology Inc (ELEV) - Elevation Oncology Reports Third Quarter 2021 Financial Results.
Elevation Oncology Inc - Qtrly Loss per Share $0.53.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.59

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.